myirislogo
01 September, 2015 05:16 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Tata Power 60.70 0.57
State Bank O 247.10 0.86
Sslt 98.60 2.34
Tata Stl 225.05 1.51
Tata Motors 340.15 0.07
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Novartis India Limited
Novartis India Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500672NSE:NOVARTINDBloomberg:HCBA@INReuters:NOIN.BO
Market Lot: 1Face Value: 5ISIN Demat: INE234A01025
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
11-AUG-15 Novartis India, one of the leading pharma companies, Monday said Novartis Healthcare (NHPL) announced the launch of Sequadra Inhaler (indacaterol / glycopyrronium) 110mcg and 50mcg, a fixed dose combination (FDC) of two bronchodilating active ingredients, indacaterol maleate, a long-acting beta2-adrenergic 28-MAY-15 Novartis India disclosed a sharp rise in standalone net profit for the quarter ended March 2015. During the quarter, ...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Novartis India tumbles 9%; clarifies against any delisting plan  -IRIS 12-Jun-15
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Mar-2015(12)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 8452.908397.808861.00
Other Income1076.40950.50831.90
Total Income9529.309348.309692.90
Cost of goods sold8772.408634.708133.20
OPBDIT756.90713.601559.70
PAT791.10985.301197.30
Gross Block---
Equity capital159.80159.80159.80
EPS (Rs.)-30.8337.46
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-11.71 - 19.6215.08 - 24.94
Debt / Equity (x)---
Operating margin (% of OI) 7.9 7.616.1
Net margin (% of OI) 8.310.512.4
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Sandoz House
Shivsagar Estate
Dr. Annie Besant Road
Worli
Mumbai
Maharashtra-400 018
PHONE
(022) 2495 8675/ 8400
FAX
(022) 2493 8666
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer